DOP2005000248A - Agentes citotoxicos que comprendentaxanos nuevos. - Google Patents
Agentes citotoxicos que comprendentaxanos nuevos.Info
- Publication number
- DOP2005000248A DOP2005000248A DO2005P000248A DO2005000248A DOP2005000248A DO P2005000248 A DOP2005000248 A DO P2005000248A DO 2005P000248 A DO2005P000248 A DO 2005P000248A DO 2005000248 A DO2005000248 A DO 2005000248A DO P2005000248 A DOP2005000248 A DO P2005000248A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- cytotoxic agents
- new
- therapeutic use
- understand new
- taxanes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVOS AGENTES CITOTOXICOS Y SU UTILIZACION TERAPEUTICA. MAS ESPECIFICAMENTE, LA INVENCION SE REFIERE A NUEVOS AGENTES CITOTOXICOS QUE COMPRENDEN TAXANOS Y SU UTILIZACION TERAPEUTICA. ESTOS NUEVOS AGENTES CITOTOXICOS TIENEN UTILIZACION TERAPEUTICA COMO RESULTADO DE PROPORCIONAR TAXANOS A UNA POBLACION CELULAR ESPECIFICA DE FORMA DIRIGIDA MEDIANTE ENLACE QUIMICO DEL TAXANO CON EL AGENTE DE UNION DE LA CELULA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04292898A EP1669358A1 (en) | 2004-12-07 | 2004-12-07 | Cytotoxic agents comprising new taxanes |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2005000248A true DOP2005000248A (es) | 2007-02-15 |
Family
ID=34931583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2005P000248A DOP2005000248A (es) | 2004-12-07 | 2005-12-06 | Agentes citotoxicos que comprendentaxanos nuevos. |
Country Status (22)
Country | Link |
---|---|
US (1) | US7667054B2 (es) |
EP (2) | EP1669358A1 (es) |
JP (1) | JP2008523019A (es) |
KR (1) | KR20070085781A (es) |
CN (1) | CN101094857A (es) |
AR (1) | AR054100A1 (es) |
AU (1) | AU2005313444B2 (es) |
BR (1) | BRPI0518869A2 (es) |
CA (1) | CA2588587A1 (es) |
DO (1) | DOP2005000248A (es) |
EA (1) | EA012625B1 (es) |
IL (1) | IL183404A0 (es) |
MA (1) | MA29103B1 (es) |
MX (1) | MX2007006765A (es) |
MY (1) | MY144632A (es) |
NO (1) | NO20073033L (es) |
NZ (1) | NZ555406A (es) |
PE (2) | PE20061060A1 (es) |
TW (1) | TW200637836A (es) |
UY (1) | UY29249A1 (es) |
WO (1) | WO2006061258A2 (es) |
ZA (1) | ZA200704790B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2552281T3 (es) | 2001-05-11 | 2015-11-26 | Ludwig Institute For Cancer Research Ltd. | Proteínas de unión específica y usos de las mismas |
US20100056762A1 (en) | 2001-05-11 | 2010-03-04 | Old Lloyd J | Specific binding proteins and uses thereof |
JP5276017B2 (ja) * | 2007-01-25 | 2013-08-28 | デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド | Egfr変異体仲介性疾患の治療における抗egfr抗体の使用 |
US20080207743A1 (en) * | 2007-02-28 | 2008-08-28 | Rodger Lamb | Biologically Active Taxane Analogs and Methods of Treatment |
WO2008115404A1 (en) * | 2007-03-15 | 2008-09-25 | Ludwing Institute For Cancer Research | Treatment method using egfr antibodies and src inhibitors and related formulations |
JP5532486B2 (ja) | 2007-08-14 | 2014-06-25 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | Egf受容体を標的とするモノクローナル抗体175ならびにその誘導体および用途 |
FR2947269B1 (fr) | 2009-06-29 | 2013-01-18 | Sanofi Aventis | Nouveaux composes anticancereux |
FR2949469A1 (fr) | 2009-08-25 | 2011-03-04 | Sanofi Aventis | Derives anticancereux, leur preparation et leur application en therapeutique |
US20110076232A1 (en) * | 2009-09-29 | 2011-03-31 | Ludwig Institute For Cancer Research | Specific binding proteins and uses thereof |
UY32913A (es) | 2009-10-02 | 2011-04-29 | Sanofi Aventis | Nuevos maitansinoides y el uso de dichos maitansinoides para preparar conjugados con un anticuero |
CN101851231A (zh) * | 2010-05-27 | 2010-10-06 | 东北林业大学 | 一种多西紫杉醇新衍生物的合成方法及其在制备抗肿瘤药物中的应用 |
FR2963007B1 (fr) | 2010-07-26 | 2013-04-05 | Sanofi Aventis | Derives anticancereux, leur preparation et leur application therapeutique |
PT3210627T (pt) | 2012-07-12 | 2023-03-23 | Hangzhou Dac Biotech Co Ltd | Conjugados de moléculas de ligação celular com agentes citotóxicos |
CN105849086B (zh) | 2012-11-24 | 2018-07-31 | 杭州多禧生物科技有限公司 | 亲水性链接体及其在药物分子和细胞结合分子共轭反应上的应用 |
DK3122757T3 (da) | 2014-02-28 | 2023-10-09 | Hangzhou Dac Biotech Co Ltd | Ladede linkere og anvendelse deraf til konjugering |
CN104693156A (zh) * | 2014-10-22 | 2015-06-10 | 上海大学 | 9,10-二羟基-1-去氧紫杉醇类似物及其制备方法 |
EP3319936A4 (en) | 2015-07-12 | 2019-02-06 | Suzhou M-conj Biotech Co., Ltd. | PLACES OF CONDUCT FOR THE CONJUGATION OF CELL BINDING MOLECULES |
US9839687B2 (en) | 2015-07-15 | 2017-12-12 | Suzhou M-Conj Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
WO2018086139A1 (en) | 2016-11-14 | 2018-05-17 | Hangzhou Dac Biotech Co., Ltd | Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5703247A (en) * | 1993-03-11 | 1997-12-30 | Virginia Tech Intellectual Properties, Inc. | 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
FR2742751B1 (fr) * | 1995-12-22 | 1998-01-30 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent |
EP1242401B1 (en) * | 1999-11-24 | 2006-12-27 | Immunogen, Inc. | Cytotoxic agents comprising taxanes and their therapeutic use |
US6596757B1 (en) * | 2002-05-14 | 2003-07-22 | Immunogen Inc. | Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use |
CN100522955C (zh) * | 2002-08-02 | 2009-08-05 | 伊缪诺金公司 | 含有新型强效紫杉烷的细胞毒性剂及其治疗用途 |
-
2004
- 2004-12-07 EP EP04292898A patent/EP1669358A1/en not_active Withdrawn
-
2005
- 2005-11-29 PE PE2005001385A patent/PE20061060A1/es not_active Application Discontinuation
- 2005-11-29 PE PE2010000952A patent/PE20110001A1/es not_active Application Discontinuation
- 2005-12-01 MY MYPI20055612A patent/MY144632A/en unknown
- 2005-12-02 KR KR1020077012679A patent/KR20070085781A/ko not_active Application Discontinuation
- 2005-12-02 EA EA200701251A patent/EA012625B1/ru not_active IP Right Cessation
- 2005-12-02 ZA ZA200704790A patent/ZA200704790B/xx unknown
- 2005-12-02 MX MX2007006765A patent/MX2007006765A/es active IP Right Grant
- 2005-12-02 NZ NZ555406A patent/NZ555406A/en not_active IP Right Cessation
- 2005-12-02 JP JP2007544849A patent/JP2008523019A/ja active Pending
- 2005-12-02 EP EP05843730A patent/EP1824858A2/en not_active Withdrawn
- 2005-12-02 CN CNA200580045888XA patent/CN101094857A/zh active Pending
- 2005-12-02 WO PCT/EP2005/014177 patent/WO2006061258A2/en active Application Filing
- 2005-12-02 CA CA002588587A patent/CA2588587A1/en not_active Abandoned
- 2005-12-02 AU AU2005313444A patent/AU2005313444B2/en not_active Expired - Fee Related
- 2005-12-02 BR BRPI0518869-5A patent/BRPI0518869A2/pt not_active IP Right Cessation
- 2005-12-05 AR ARP050105077A patent/AR054100A1/es unknown
- 2005-12-06 DO DO2005P000248A patent/DOP2005000248A/es unknown
- 2005-12-06 US US11/295,294 patent/US7667054B2/en not_active Expired - Fee Related
- 2005-12-06 TW TW094142849A patent/TW200637836A/zh unknown
- 2005-12-07 UY UY29249A patent/UY29249A1/es unknown
-
2007
- 2007-05-24 IL IL183404A patent/IL183404A0/en unknown
- 2007-06-14 NO NO20073033A patent/NO20073033L/no not_active Application Discontinuation
- 2007-06-18 MA MA30008A patent/MA29103B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005313444B2 (en) | 2011-11-10 |
WO2006061258A2 (en) | 2006-06-15 |
MA29103B1 (fr) | 2007-12-03 |
AR054100A1 (es) | 2007-06-06 |
CA2588587A1 (en) | 2006-06-15 |
TW200637836A (en) | 2006-11-01 |
WO2006061258A3 (en) | 2006-09-28 |
US7667054B2 (en) | 2010-02-23 |
ZA200704790B (en) | 2008-08-27 |
JP2008523019A (ja) | 2008-07-03 |
US20060178427A1 (en) | 2006-08-10 |
MX2007006765A (es) | 2007-08-16 |
IL183404A0 (en) | 2007-10-31 |
EA200701251A1 (ru) | 2007-12-28 |
PE20110001A1 (es) | 2011-01-21 |
AU2005313444A1 (en) | 2006-06-15 |
KR20070085781A (ko) | 2007-08-27 |
BRPI0518869A2 (pt) | 2008-12-16 |
NO20073033L (no) | 2007-08-28 |
EP1824858A2 (en) | 2007-08-29 |
PE20061060A1 (es) | 2006-11-14 |
MY144632A (en) | 2011-10-14 |
CN101094857A (zh) | 2007-12-26 |
EP1669358A1 (en) | 2006-06-14 |
EA012625B1 (ru) | 2009-10-30 |
UY29249A1 (es) | 2006-06-30 |
NZ555406A (en) | 2011-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2005000248A (es) | Agentes citotoxicos que comprendentaxanos nuevos. | |
PA8654601A1 (es) | Agentes citotoxicos que comprenden taxanos nuevos | |
GT201000008A (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico | |
NI201000044A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
UY29086A1 (es) | Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos. | |
HN2008000188A (es) | 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion | |
HN2005000795A (es) | Pirimidinas como antagonistas del receptor de prostaglandina d2 | |
CU24349B1 (es) | Composiciones que comprenden 2,3-dihidroimidazo [1,2-c] quinazolinas sustituidas útiles para el tratamiento del cáncer | |
UY31816A (es) | Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras | |
CO6501131A2 (es) | Antagonistas de espiro-oxindol de mdm2 | |
SV2008003071A (es) | Composiciones farmaceuticas de antagonistas del anticuerpo anti-cd40 | |
GT200500321A (es) | Compuestos y composiciones como inhibidores de proteina kinase. | |
PA8600601A1 (es) | Ligandos de receptores de cannabinoides y sus usos | |
PA8576901A1 (es) | Moduladores del receptor de glucocorticoides | |
SV2009003393A (es) | Polipeptidos de factor vii modificaciones y usos de los mismos | |
NI201000015A (es) | Bromhidrato de bupropión y aplicaciones terapéuticas | |
CL2011003065A1 (es) | Formulacion vesicular que comprende uno o mas fosfolipidos y uno o mas surfactantes no ionicos, libre de cualquier agente farmaceuticamente activo, util para el tratamiento del dolor asociado con osteoartritis. | |
ECSP066805A (es) | Compuestos silinano como inhibidores de cisteína proteasa | |
AR082155A1 (es) | Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido | |
PE20081881A1 (es) | Agentes terapeuticos para canceres resistentes a agentes quimioterapicos que incluyen como ingrediente activo un anticuerpo que reconoce hla de clase i y sus usos | |
UY29387A1 (es) | Imidazoles sustituidos con heterociclilamida. | |
CR11529A (es) | Compuestos de cicloalquiloxi y heterocicloalquilopiridina como moduladores del receptor de h3 de histamina | |
ATE399532T1 (de) | Medizinische seife | |
BRPI0911573A2 (pt) | preservativo com agente ativo localizado. | |
ECSP12012132A (es) | Combinación de teobromina con un descongestivo y su uso para el tratamiento de la tos |